Literature DB >> 204233

Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves.

J S Brar, D W Johnson, C C Muscoplat, R E Shope, J C Meiske.   

Abstract

The immune response to modified live-virus bovine viral diarrhea (BVD) vaccine and infectious bovine rhinotracheitis (IBR) vaccine was examined in calves that had received passive maternal antibodies to these viruses. Blood serum samples from vaccinated and control (nonvaccinated) calves were examined for more than 1 year to determine the rate of decline of passive anti-BVD and anti-IBR antibodies and the effect that vaccination had on these antibody titers. The control calves lost their antibodies to BVD and IBR viruses at the rate of one half their remaining antibody titer every 21 days. Calves serologically responded to BVD vaccine at a time when maternal antibody titers remained between 1:96 and 1:20. However, animals did not seroconvert to the IBR vaccine until maternal antibodies had decreased and become undetectable. Evidence is presented to show that although passive immunity will inhibit IBR vaccination, priming for a secondary response will occur so that on subsequent vaccination, at a time when maternal antibodies have disappeared, the animals will respond anamnestically to IBR vaccination.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204233

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  17 in total

1.  A blocking ELISA with improved sensitivity for the detection of passively acquired maternal antibodies to BHV-1.

Authors:  Hyun Ju Cho; Susan C Entz; G Tom Green; Lorne T Jordan
Journal:  Can Vet J       Date:  2002-01       Impact factor: 1.008

2.  Bovine respiratory disease: commercial vaccines currently available in Canada.

Authors:  S L Bowland; P E Shewen
Journal:  Can Vet J       Date:  2000-01       Impact factor: 1.008

3.  The effect of a combined Pasteurella haemolytica and Haemophilus somnus vaccine and a modified-live bovine respiratory syncytial virus vaccine against enzootic pneumonia in young beef calves.

Authors:  J Van Donkersgoed; A A Potter; B Mollison; R J Harland
Journal:  Can Vet J       Date:  1994-04       Impact factor: 1.008

4.  Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency.

Authors:  M Lemaire; V Weynants; J Godfroid; F Schynts; G Meyer; J J Letesson; E Thiry
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines.

Authors:  A M Menanteau-Horta; T R Ames; D W Johnson; J C Meiske
Journal:  Can J Comp Med       Date:  1985-01

6.  Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves.

Authors:  M Lemaire; G Meyer; E Baranowski; F Schynts; G Wellemans; P Kerkhofs; E Thiry
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  A seroepidemiological study of the importance in cow-calf pairs of respiratory and enteric viruses in beef operations from northwestern Quebec.

Authors:  R Ganaba; D Bélanger; S Dea; M Bigras-Poulin
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

8.  Observations on an outbreak of infectious bovine rhinotracheitis in a bull test station.

Authors:  E D Janzen; J N Smart; H H Nicholson
Journal:  Can Vet J       Date:  1980-01       Impact factor: 1.008

9.  The effect of maternally derived antibodies on the response of calves to vaccination against foot and mouth disease.

Authors:  M J Nicholls; L Black; M M Rweyemamu; J Genovese; R Ferrari; C A Hammant; E de Silva; O Umehara
Journal:  J Hyg (Lond)       Date:  1984-02

10.  New concepts in the pathogenesis, diagnosis and control of diseases caused by the bovine viral diarrhea virus.

Authors:  O M Radostits; I R Littlejohns
Journal:  Can Vet J       Date:  1988-06       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.